067630.KQ
HLB Life Science Co., Ltd.
KOE · Utilities · Renewable Utilities · KR
KRW 2,630.00
−1.13%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 54.4B | 45.8B | 102.2B | 98.0B | 99.6B |
| Cost of Revenue | 58.5B | 47.8B | 104.4B | 98.7B | 104.2B |
| Gross Profit | (4.1B) | (2.0B) | (2.2B) | (748.6M) | (4.6B) |
| Operating Expenses | |||||
| R&D Expense | 4.2B | 4.7B | 5.2B | 5.5B | 4.3B |
| SG&A Expense | 7.0B | 4.5B | 5.0B | 5.5B | 3.8B |
| General & Admin Expense | 809.1M | 1.1B | 1.2B | 1.1B | 1.3B |
| Selling & Marketing Expense | 3.2B | 3.3B | 3.8B | 4.4B | 2.5B |
| Other Expenses | 8.6B | 9.8B | 12.5B | 12.8B | (192.7M) |
| Total Operating Expenses | 18.9B | 19.0B | 22.6B | 23.8B | 15.4B |
| Cost and Expenses | 77.4B | 66.8B | 127.1B | 122.5B | 119.5B |
| Operating Income (EBIT) | (23.0B) | (21.0B) | (21.0B) | (24.5B) | (19.9B) |
| Non-Operating | |||||
| Interest Income | 2.0B | 2.2B | 1.8B | 1.3B | 1.2B |
| Interest Expense | 12.3B | 11.7B | 16.8B | 21.7B | 9.9B |
| Net Interest Income | (10.3B) | (9.5B) | (15.0B) | (20.4B) | (8.6B) |
| Other Non-Op Income/Expense | (10.6B) | (79.2B) | 23.6B | 18.0B | (40.9B) |
| Non-Operating Income (excl Interest) | 2.2B | 67.8B | (42.0B) | (39.7B) | 31.0B |
| EBT (Pre-Tax Income) | (33.6B) | (100.6B) | 3.1B | (6.5B) | (63.4B) |
| Income Tax Expense | (504.6M) | (666.7M) | (3.1B) | (590.1M) | (6.5B) |
| Bottom Line | |||||
| Net Income | (33.0B) | (99.8B) | 6.1B | (6.0B) | (54.3B) |
| Earnings from Cont. Ops | (33.1B) | (99.8B) | 6.2B | (5.9B) | (54.4B) |
| Earnings from Discont. Ops | — | (44.9M) | — | — | — |
| Bottom Line Net Income | (33.2B) | (99.8B) | 6.1B | (6.0B) | (54.3B) |
| Per Share | |||||
| Basic EPS | (₩272) | (₩819) | ₩54 | (₩55) | (₩538) |
| Diluted EPS | (₩272) | (₩819) | ₩54 | (₩55) | (₩538) |
| Revenue Per Share | ₩446 | ₩375 | ₩907 | ₩897 | ₩986 |
| Shares | |||||
| Basic Shares Outstanding | 121.8M | 121.9M | 112.7M | 109.2M | 101.0M |
| Diluted Shares Outstanding | 121.8M | 121.9M | 112.7M | 109.2M | 101.0M |
| Profitability Metrics | |||||
| EBITDA | (45.6B) | (15.8B) | 26.8B | 22.8B | (46.0B) |
| D&A | 7.6B | 5.2B | 5.9B | 7.7B | 5.0B |
| EBIT | (53.2B) | (21.0B) | 20.9B | 15.1B | (51.0B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026